Clinical trial
Effect of Oral Zinc Given Daily Between Days 2 and 7 of Life to Term or Near Term Neonates With Serum Bilirubin Levels of More Than 6 mg/dL at 24 ± 6 Hours of Life on Hyperbilirubinemia and Phototherapy
NCT00692224 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Oral Zinc Given Daily Between Days 2 and 7 of Life to Term or Near Term Neonates With Serum Bilirubin Levels of More Than 6 mg/dL at 24 ± 6 Hours of Life on Hyperbilirubinemia and Phototherapy
- Lead sponsor
- All India Institute of Medical Sciences
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- October 31, 2006
- Enrollment
- 294 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal jaundice